Mitochondrial mitophagy in mesenteric artery remodelling in hyperhomocysteinemia

Physiological Reports

Volumn 2, Issue 4, 2014, Pages

  Familtseva, Anastasia ^a   Kalani, Anuradha ^a   Chaturvedi, Pankaj ^a   Tyagi, Neetu ^a   Metreveli, Naira ^a   Tyagi, Suresh C ^a  

^a University of Louisville School of Medicine   (United States)

Author keywords

Endothelial dysfunction; Hyperhomocysteinemia; Mitochondrial dynamics; Oxidative stress

Indexed keywords

ALBUMIN; CD31 ANTIGEN; CONNEXIN 40; HOMOCYSTEINE; NITRIC OXIDE SYNTHASE;

ANIMAL CELL; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BREEDING; CELL DAMAGE; CELL LOSS; CONTROLLED STUDY; ENDOTHELIAL DYSFUNCTION; ENTERITIS; FEMALE; GENOTYPE; HISTOLOGY; HYPERHOMOCYSTEINEMIA; IMMUNOHISTOCHEMISTRY; MALE; MESENTERIC ARTERY; MITOCHONDRIAL DYNAMICS; MITOPHAGY; MOUSE; NONHUMAN; OXIDATIVE STRESS; PHENOTYPE; PROTEIN EXPRESSION; REAL TIME POLYMERASE CHAIN REACTION; WESTERN BLOTTING;

EID: 85003601601     PISSN: None     EISSN: 2051817X     Source Type: Journal    
DOI: 10.14814/phy2.283     Document Type: Article

References (38)

1. Chambers, J. C., A. McGregor, J. Jean-Marie, O. A. Obeid, and J. S. Kooner. 1999. Demonstration of rapid onset vascular endothelial dysfunction after hyperhomocysteinemia: an effect reversible with vitamin C therapy. Circulation 99:1156-1160.
2. Chen, C., B. S. Conklin, Z. Ren, and D. S. Zhong. 2002. Homocysteine decreases endothelium-dependent vasorelaxation in porcine arteries. J. Surg. Res. 102:22-30.
3. Davidson, S. M., and M. R. Duchen. 2007. Endothelial mitochondria: contributing to vascular function and disease. Circ. Res. 100:1128-1141.
4. De Wit, C., F. Roos, S. S. Bolz, S. Kirchhoff, O. Kruger, K. Willecke, et al. 2000. Impaired conduction of vasodilation along arterioles in connexin40-deficient mice. Circ. Res. 86:649-655.
5. Dranka, B. P., B. G. Hill, and V. M. Darley-Usmar. 2010. Mitochondrial reserve capacity in endothelial cells: the impact of nitric oxide and reactive oxygen species. Free Radic. Biol. Med. 48:905-914.
6. Edirimanne, V. E., C. W. Woo, Y. L. Siow, G. N. Pierce, J. Y. Xie, and O. Karmin. 2007. Homocysteine stimulates NADPH oxidase-mediated superoxide production leading to endothelial dysfunction in rats. Can. J. Physiol. Pharmacol. 85:1236-1247.
7. Fu, W. Y., N. P. Dudman, M. A. Perry, and X. L. Wang. 2002. Homocysteine attenuates hemodynamic responses to nitric oxide in vivo. Atherosclerosis 161:169-176.
8. Ganapathy, P. S., R. L. Perry, A. Tawfik, R. M. Smith, E. Perry, P. Roon, et al. 2011. Homocysteine-mediated modulation of mitochondrial dynamics in retinal ganglion cells. Invest. Ophthalmol. Vis. Sci. 52:5551-5558.
9. Givvimani, S., C. Munjal, N. Narayanan, F. Aqil, G. Tyagi, N. Metreveli, et al. 2012a. Hyperhomocysteinemia decreases intestinal motility leading to constipation. Am. J. Physiol. Gastrointest. Liver Physiol. 303:G281-G290.
10. Givvimani, S., C. Munjal, N. Tyagi, U. Sen, N. Metreveli, and S. C. Tyagi. 2012b. Mitochondrial division/mitophagy inhibitor (Mdivi) ameliorates pressure overload induced heart failure. PLoS ONE 7:e32388.
11. Gradman, W. S., J. Daniel, B. Miller, and M. Haji-Aghaii. 2001. Homocysteine-associated acute mesenteric artery occlusion treated with thrombectomy and bowel resection. Ann. Vasc. Surg. 15:247-250.
12. Grohm, J., S. W. Kim, U. Mamrak, S. Tobaben, A. Cassidy-Stone, J. Nunnari, et al. 2012. Inhibition of Drp1 provides neuroprotection in vitro and in vivo. Cell Death Differ. 19:1446-1458.
13. Heil, S. G., A. S. De Vriese, L. A. Kluijtmans, S. Mortier, M. Den Heijer, and H. J. Blom. 2004. The role of hyperhomocysteinemia in nitric oxide (NO) and endothelium-derived hyperpolarizing factor (EDHF)-mediated vasodilatation. Cell. Mol. Biol. (Noisy-le-grand) 50:911-916.
14. Jung, K. J., H. S. Jang, J. I. Kim, S. J. Han, J. W. Park, and K. M. Park. 1832. Involvement of hydrogen sulfide and homocysteine transsulfuration pathway in the progression of kidney fibrosis after ureteral obstruction. Biochim. Biophys. Acta 1989-1997:2013.
15. Kamat, P. K., A. Kalani, S. Givvimani, P. B. Sathnur, S. C. Tyagi, and N. Tyagi. 2013. Hydrogen sulfide attenuates neurodegeneration and neurovascular dysfunction induced by intracerebral-administered homocysteine in mice. Neuroscience 252C:302-319.
16. Lambert, D., S. Benhayoun, C. Adjalla, M. A. Gelot, P. Renkes, F. Felden, et al. 1996. Crohn’s disease and vitamin B12 metabolism. Dig. Dis. Sci. 41:1417-1422.
17. Latorre, E., C. Mendoza, E. Layunta, A. I. Alcalde, and J. E. Mesonero. 2013. TLR2, TLR3, and TLR4 activation specifically alters the oxidative status of intestinal epithelial cells. Cell Stress & Chaperones 19:289-293.
18. Makino, A., B. T. Scott, and W. H. Dillmann. 2010. Mitochondrial fragmentation and superoxide anion production in coronary endothelial cells from a mouse model of type 1 diabetes. Diabetologia 53:1783-1794.
19. Marzetti, E., A. Csiszar, D. Dutta, G. Balagopal, R. Calvani, and C. Leeuwenburgh. 2013. Role of mitochondrial dysfunction and altered autophagy in cardiovascular aging and disease: from mechanisms to therapeutics. Am. J. Physiol. Heart Circ. Physiol. 305:H459-H476.
20. Mather, S., K. A. Dora, S. L. Sandow, P. Winter, and C. J. Garland. 2005. Rapid endothelial cell-selective loading of connexin 40 antibody blocks endothelium-derived hyperpolarizing factor dilation in rat small mesenteric arteries. Circ. Res. 97:399-407.
21. Mendes, R. H., R. A. Sirvente, G. O. Candido, C. Mostarda, V. M. Salemi, V. D’Almeida, et al. 2010. Homocysteine thiolactone induces cardiac dysfunction: role of oxidative stress. J. Cardiovasc. Pharmacol. 55:198-202.
22. Mishra, P. K., N. Tyagi, U. Sen, I. G. Joshua, and S. C. Tyagi. 2010. Synergism in hyperhomocysteinemia and diabetes: role of PPAR gamma and tempol. Cardiovasc. Diabetol. 9:49.
23. Mohazzab, K. M., and M. S. Wolin. 1994. Sites of superoxide anion production detected by lucigenin in calf pulmonary artery smooth muscle. Am. J. Physiol. 267:L815-L822.
24. Mohazzab, K. M., P. M. Kaminski, and M. S. Wolin. 1994. NADH oxidoreductase is a major source of superoxide anion in bovine coronary artery endothelium. Am. J. Physiol. 266:H2568-H2572.
25. Munjal, C., S. Givvimani, N. Qipshidze, N. Tyagi, J. C. Falcone, and S. C. Tyagi. 2011. Mesenteric vascular remodeling in hyperhomocysteinemia. Mol. Cell. Biochem. 348:99-108.
26. Oussalah, A., J. L. Gueant, and L. Peyrin-Biroulet. 2011. Meta-analysis: hyperhomocysteinaemia in inflammatory bowel diseases. Aliment. Pharmacol. Ther. 34:1173-1184.
27. Pangare, M., and A. Makino. 2012. Mitochondrial function in vascular endothelial cell in diabetes. J. Smooth Muscle Res. 48:1-26.
28. Park, E. J., H. N. Umh, S. W. Kim, M. H. Cho, J. H. Kim, and Y. Kim. 2013. ERK pathway is activated in bare-FeNPs-induced autophagy. Arch. Toxicol. 88:323-336.
29. Peng, L., X. Men, W. Zhang, H. Wang, S. Xu, Q. Fang, et al. 2012. Involvement of dynamin-related protein 1 in free fatty acid-induced INS-1-derived cell apoptosis. PLoS ONE 7: e49258.
30. Pradeep, H., and G. K. Rajanikant. 2013. In silico identification of potential dynamin-related protein 1 antagonists: implications for diseases involving mitochondrial dysfunction. Comb. Chem. High Throughput Screen. 17:25-34.
31. Qipshidze, N., N. Metreveli, D. Lominadze, and S. C. Tyagi. 2011. Folic acid improves acetylcholine-induced vasoconstriction of coronary vessels isolated from hyperhomocysteinemic mice: an implication to coronary vasospasm. J. Cell. Physiol. 226:2712-2720.
32. Shenouda, S. M., M. E. Widlansky, K. Chen, G. Xu, M. Holbrook, C. E. Tabit, et al. 2011. Altered mitochondrial dynamics contributes to endothelial dysfunction in diabetes mellitus. Circulation 124:444-453.
33. Small, C. L., S. A. Reid-Yu, J. B. McPhee, and B. K. Coombes. 2013. Persistent infection with Crohn’s disease-associated adherent-invasive Escherichia coli leads to chronic inflammation and intestinal fibrosis. Nat. Commun. 4:1957.
34. Trudeau, K., A. J. Molina, W. Guo, and S. Roy. 2010. High glucose disrupts mitochondrial morphology in retinal endothelial cells: implications for diabetic retinopathy. Am. J. Pathol. 177:447-455.
35. Tyagi, S. C., W. Rodriguez, A. M. Patel, A. M. Roberts, J. C. Falcone, J. C. Passmore, et al. 2005. Hyperhomocysteinemic diabetic cardiomyopathy: oxidative stress, remodeling, and endothelial-myocyte uncoupling. J. Cardiovasc. Pharmacol. Ther. 10:1-10.
36. Tyagi, N., M. Kandel, C. Munjal, N. Qipshidze, J. C. Vacek, S. B. Pushpakumar, et al. 2011. Homocysteine mediated decrease in bone blood flow and remodeling: role of folic acid. J. Orthop. Res. 29:1511-1516.
37. Van den Berg, M., G. H. Boers, D. G. Franken, H. J. Blom, G. J. Van Kamp, C. Jakobs, et al. 1995. Hyperhomocysteinaemia and endothelial dysfunction in young patients with peripheral arterial occlusive disease. Eur. J. Clin. Invest. 25:176-181.
38. Wilcken, D. E., X. L. Wang, T. Adachi, H. Hara, N. Duarte, K. Green, et al. 2000. Relationship between homocysteine and superoxide dismutase in homocystinuria: possible relevance to cardiovascular risk. Arterioscler. Thromb. Vasc. Biol. 20:1199-1202.